COOPER COMPANIES, INC. (COO)
Ophthalmic Goods
Latest Price
$72.32
TTM P/E
61.81
Normalized P/E
17.28
Div Yield
--
Book Value
42.25
P/B Ratio
1.71
Valuation metrics
adjust assumptions →EPS: $1.87
Book value / share: $42.06
Formula: √(22.5 × EPS × BVPS)
Graham Number
$42.07
42% downside
Norm. op. income: $533M (median of 7yr)
Tax rate: 24%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$8.52
88% downside
Base FCF: $434M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$26.84
63% downside
EPS: $1.87
Target P/E: 17×
Formula: EPS × P/E
P/E Fair Value
$31.79
56% downside
Institutional Ownership
99.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 16.62M | $1.19B | 8.53% | +131.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.72M | $909.0M | 6.53% | -- | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 9.06M | $647.0M | 4.65% | +3.16M | 2026-03-31 |
| STATE STREET CORP | 8.77M | $626.0M | 4.50% | -25.3K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8.72M | $623.0M | 4.47% | -- | 2026-03-31 |
| Capital World Investors | 7.41M | $530.0M | 3.80% | -2.79M | 2026-03-31 |
| BROWNING WEST LP | 6.98M | $499.0M | 3.58% | +3.29M | 2026-03-31 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 6.62M | $473.0M | 3.39% | -582.2K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.39M | $385.0M | 2.77% | -634.9K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.31M | $378.0M | 2.73% | +36.8K | 2026-03-31 |